drugset / Trial / NCT01294241

Oleogel-S10 in Wound Healing of Inherited Epidermolysis Bullosa (BEB-10)

NCT01294241

Phase 2 Completed 10 enrolled Birken AG
Non-randomizedSingle-groupSingle-blindTreatment

Summary

The purpose of this study was to compare intra-individually the reepithelialization of skin lesion(s) in inherited Epidermolysis bullosa (either 1 wound ≥10 cm2 and ≤200 cm2 in size divided in 2 equal halves or 2 comparable wounds of ≥5 cm2 each) treated with Oleogel-S10 and non-adhesive wound dressing versus non-adhesive wound dressing only.

Timeline

Start
2010-11
Primary completion
2011-06
Completion
2011-06

Drugs

EvaluationDrugModalityDoseRoute
Subject BIRCH TRITERPENES Small molecule 115 mg Topical